Nikolai Petrovsky: Covax19/Spikogen®; the first approved recombinant spike protein vaccine
Published 2022-04-01Download video
Recommendations
-
59:08 Ethan Shevach: Tregs - ready for the clinic?
-
51:06 Professor Adrian Hill: A rapid vaccine response to COVID-19: progress and prospects
-
25:42 Narasimha Rao: FDA recommendations on immunogenicity risk assessment for synthetic peptide drugs
-
20:14 Genevieve Clutton: CD3 downregulation identifies high-avidity human CD8 T cells
-
1:12:55 How do many-eyed animals see the world? With Dr Lauren Sumner-Rooney
-
36:50 Bruce Hall: Antigen specific CD4+CD25+Foxp3+Treg generated from natural Treg (nTreg)
-
26:06 My Diagnosis
-
50:49 Book at Lunchtime: Thinking with Literature
-
10:15 Self-Compassion and Depression with Kristin Neff, Mark Williams and Willem Kuyken
-
19:16 Ashley Curran: Citrullination alters antigen processing and presentation by revealing epitopes in RA
-
12:30 Psychiatric Interviews for Teaching: Psychosis
-
04:01 Why was Dorothy Hodgkin's research revolutionary?
-
1:15:58 Kyoto Prize at Oxford Lecture: Dr Tasuku Honjo: Serendipities of Acquired Immunity
-
45:56 Prevention of stroke and dementia - lecture by Prof. Peter M Rothwell
-
59:46 Mindfulness Based Cognitive Therapy by Prof Willem Kuyken, University of Oxford Mindfulness Centre
-
2:10:49 Neuroscientist Reveals The Truth About Memory & How We Can Remember Better | Charan Ranganath
-
09:51 Psychiatric Interviews for Teaching: Mania
-
48:57 Exploring the demographic transition in the 21st Century
-
1:32:27 Mariana Mazzucato: The value of everything: rediscovering purpose in the economy
-
31:19 COVID conversations: William James on Viral Pathogenesis
Similar videos
-
35:19 Global SARS-CoV-2 Expert Symposium 2022: Panel Discussion 1
-
1:16:54 What Really Happened in Wuhan: Nikolai Petrovsky | The Australian
-
12:58 ‘Protein-based vaccines will rescue immunity in those who have had an mRNA vaccine’: Petrovsky.
-
10:46 Australian professor says 'lot of different routes' possible for Covid-19 lab leak theory | Q+A 2021
-
1:01:44 [Webinar] Probing Antibody Binding to the SARS-CoV-2 Spike Protein
-
02:41 COVAX-19 The Phase 2B clinical Trial commences in South Australia
-
48:31 Episode Four -Vaxine Pty Ltd COVAX-19 discussion video Prof Petrovsky
-
12:31 Episode Three -Vaxine Pty Ltd COVAX-19 discussion video Prof Petrovsky
-
12:21 Episode Two -Vaxine Pty Ltd COVAX-19 discussion video Prof Petrovsky
-
16:08 Andrew Isidoridy: Evaluating immunogenicity risk of complex peptide products
-
13:47 South Australian Vaccine headed for TGA approval
-
31:11 Jeremy Fry: An Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design
-
38:19 Andrea Ferrante: Assessment of MHC class II-restricted epitope prediction in silico
-
29:40 Jeremy Fry: An integrated approach to managing immunogenicity risk and drug immune modulation
-
56:55 Jeremy Fry: Tools and Technologies for Immunogenicity Risk Management
-
26:35 First Look at Aussie Vaccine COVAX-19 (Spikogen)
-
1:35:47 Furin Cleavage Site Is Key To Covid's Origin: Nikolai Petrovsky w/ Dr. Kelly Victory – Ask Dr. Drew
-
03:14 What is a mRna Vaccine?? Explained by Professor Nikolai Petrovsky
-
58:04 Maia Chakerian, MD, interviews Jan Marini